Cardio Diagnostics Holdings, Inc. — Investor Relations & Filings
Filings indexed
274
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CDIO
Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in the development and commercialization of clinical tests for cardiovascular disease. The company leverages a proprietary platform that integrates artificial intelligence with epigenetics and genetics to enable early detection and prevention of heart disease. Its primary products are blood-based tests, including Epi+Gen CHD and PrecisionCHD™, which assess a patient's risk for coronary heart disease. These diagnostic tools analyze an individual's unique genetic and epigenetic markers to provide personalized insights, aiming to make cardiovascular care more precise and accessible for clinicians and patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - CARDIO DIAGNOSTICS HOLDINGS, INC. (0001870144) (Filer) | 2026-02-19 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46362674 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 32900184 | 8-K - CARDIO DIAGNOSTICS HOLDINGS, INC. (0001870144) (Filer) | 2026-02-19 | English | ||
| 13489635 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489636 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489637 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489638 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
|
2025
9 filings
| |||||
| 13489639 | FORM 10-Q | 2025-11-12 | English | ||
| 13489640 | FORM 8-K | 2025-10-15 | English | ||
| 13489641 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489642 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489643 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489644 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489645 | PROSPECTUS | 2025-09-23 | English | ||
| 13489646 | Regulatory Filings 2025 | 2025-09-22 | English | ||
| 13489647 | POST-EFFECTIVE AMENDMENT NO. 1 | 2025-09-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ACROBIOSYSTEMS CO.,LTD.
Provides recombinant proteins and reagents for life science…
|
301080 | CN | Professional, scientific and te… |
|
ACTINOGEN MEDICAL LIMITED
Developing cortisol-inhibiting therapies for Alzheimer's an…
|
ACW | AU | Professional, scientific and te… |
|
Active Biotech
Biotechnology company developing drugs for oncology and inf…
|
ACTI | SE | Professional, scientific and te… |
|
Adagene Inc.
Clinical-stage biotech developing antibody-based immunother…
|
ADAG | KY | Professional, scientific and te… |
|
ADALTA LIMITED
Clinical-stage biotech developing i-body protein therapeuti…
|
1AD | AU | Professional, scientific and te… |
|
Adaptive Biotechnologies Corp
Decodes the adaptive immune system to develop products for …
|
ADPT | US | Professional, scientific and te… |
|
Adeia Inc.
R&D company that licenses IP for the media, entertainment, …
|
ADEA | US | Professional, scientific and te… |
|
Aditxt, Inc.
Acquires, develops, and deploys health technologies to addr…
|
ADTX | US | Professional, scientific and te… |
|
Advanced Biomed Inc.
Develops microfluidic biochip diagnostic systems for precis…
|
ADVB | US | Professional, scientific and te… |
|
Advanced Proteome Therapeutics Corporation
Develops proprietary technology for chemical modification o…
|
APC.H | CA | Professional, scientific and te… |
Cardio Diagnostics Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35336/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35336 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35336 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35336 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35336}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cardio Diagnostics Holdings, Inc. (id: 35336)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.